Neurodegenerative Diseases Clinical Trial
The diagnosis of neurodegenerative conditions and ADHD still mostly relies on clinical
symptoms as there are no validated, inexpensive, and simple bio- markers available yet. The
purpose of this study is to deliver a proof-of-concept for novel biomarkers to identify
neurodegenerative conditions and ADHD based on breath testing.
Alveolar breath will be collected from healthy volunteers, patients with extrapyramidal
conditions, patients diagnosed with dementia and from ADHD subjects. The discriminative
power of a tailor-made Nanoscale Artificial Nose (™NA-NOSE) containing an array of six
nanomaterial-based sensors will be tested. Discriminant factor analysis will be applied to
the NA-NOSE signals in order to detect statistically significant differences between the
sub-populations, and classification success will be estimated using leave-one-out
cross-validation. The identification of NA-NOSE patterns will be supported by analyzing the
chemical composition of the breath using gas-chromatography in conjunction with
mass-spectrometry (GC-MS).
n/a
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Completed |
NCT05788133 -
The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.
|
N/A | |
| Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
| Completed |
NCT03295786 -
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04265482 -
Community-based Cohort of Functional Decline in Subjective Cognitive Complaint Elderly
|
||
| Not yet recruiting |
NCT02222779 -
Quantification of Transition Metals
|
N/A | |
| Completed |
NCT01450891 -
Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease
|
N/A | |
| Completed |
NCT01953523 -
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
|
N/A | |
| Recruiting |
NCT06148233 -
CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging
|
N/A | |
| Completed |
NCT03538522 -
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
|
Phase 2 | |
| Completed |
NCT06251830 -
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
|
||
| Recruiting |
NCT04472130 -
Neurodegenerative Diseases Registry
|
||
| Completed |
NCT03353207 -
Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for Neurodegeneration
|
||
| Completed |
NCT05095870 -
Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
|
||
| Recruiting |
NCT05784090 -
Correlation Between Melatonin Levels in Different Biological Fluids
|
||
| Completed |
NCT02108769 -
Yogic Breathing Changes Salivary Components
|
N/A | |
| Recruiting |
NCT05508789 -
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
|
Phase 3 | |
| Recruiting |
NCT05235802 -
Long-term Follow-up in Severe Traumatic Brain Injury
|
||
| Recruiting |
NCT04820881 -
Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury
|
||
| Completed |
NCT06180213 -
Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma
|